Abstract:Diabetes mellitus is increasing in prevalence, affecting more than 5% of the population throughout the world. Novel therapeutic strategies, including new medications, islet transplantation, and gene therapy, are vigorously being sought to treat diabetes. Direct in vivo pancreatic gene delivery targeting the islets is a key approach for diabetic gene therapy. So far studies have shown that the adenovirus, adeno-associated virus, lentivirus, and herpes simplex virus-1 vectors can be used for efficient gene transfer to the islets in vivo, but suffered from host immune responses and vector cytotoxicity. Non-viral gene delivery systems, including naked DNA and DNA complexes, have also demonstrated islet cell transfection at much lower levels and with transient transgene expression over time. However, it seems likely that non-viral vector systems will more easily satisfy bio-safety concerns in clinical trials. Our new gene therapy approach, ultrasound-targeted micro-bubble destruction (UTMD), has shown that it is able to deliver genes to the pancreas in vivo. Briefly, genes are incorporated into cationic liposome and then attached to the phospholipids shell of gas-filled micro-bubble, which are then injected intravenously and destroyed within the microcirculation of intact islets by ultrasound. This approach enables transfection of the entire islet core, wherein most beta cells reside. Our current study focuses on how to construct gene therapy vectors that can drive functional gene expression in beta cells efficiently. We now demonstrate differential efficiency of gene expression by varying the length of the RIP segments. We attempted to expand the insulin gene promoter from the traditional area to the non-coding region in exon1, intron1 and part of exon2 of the rat insulin gene 1 with a downstream reporter gene in the plasmid construction. We report that UTMD delivers this rat insulin promoter driving the reporter vectors to intact islets of adult, living animals, providing a relative safety, tissue-specific, high efficient and regulated gene expression for diabetic gene therapy.

Construction of the retrovirus vectors carrying the IL-17 or siRNA-IL-17 genes and expression of IL-17 gene in the transgenic diabetogenic T cells

Construction and Identification of Retro Viral Vector Expressing Human Interleukin-17 Gene

Construction of Human IL-17F-recombinant Retrovirus Vector and Its Stable Expression in 293T Cells

Foxp3-expressing CD4+T Cells under the Control of IFN-γ Promoter Prevent Diabetes in NOD Mice

Retroviral CRISPR/Cas9-Mediated Gene Targeting for the Study of Th17 Differentiation in Vitro

Interleukin-17 mediates the pathogenesis of diabetes induced by diabetogenic T lymphocytes in NOD mice

Construction of Retroviral Vector Encoding Human Insulin-like Growth Factor-1 and Its Expression in Bone Marrow Stromal Cells

Diabetes is Not Prevented by Foxp3-transduced CD4+T Cells under the IL-12Rβ2 Promoter Control

Diabetes is Not Prevented by Foxp3-Transduced Cd4(+)T Cells under the Il-12r Beta 2 Promoter Control

Rerovirus Mediated Hsv-Tk Gene Transfer Can Influence The Function Of Human T-Lymphocyte

Efficient, Glucose Responsive, and Cell-Specific Transgene Expression in Pancreatic Islets.

Interleukin‐17‐producing Γδ+ T Cells Protect NOD Mice from Type 1 Diabetes Through a Mechanism Involving Transforming Growth Factor‐β

Construction of recombinant adenovirus vector expressing hIL-17F and functional study of expressed IL-17 F

Lentiviral Vectors with Amplified Beta Cell-Specific Gene Expression

Construction of vector pCAG-Z-eGFP-mIR for T cell specific expression of mouse IR

Construction of Retroviral Vectors to Induce a Strong Expression of Human Class Interferon Gene in Human Hepatocellular Carcinoma Cellsin Vitro

Construction of a High Efficient Retrovirus Vector Psiv-1 and Its Preliminary Identification of Functions

Construction and Identification of Retroviral Vector Expressing TH Gene

Construction of Retroviral Vectors to Induce Strong Hepatoma Cell‐specific Expression of Cytokine Genes

Construction and Identification of Recombinant Adenovirus Harboring the GIP-Human Insulin Gene

Construction of lentiviral vector specific for mouse B7-1 gene interference and study on silencing effects induced by lentivirus-mediated B7-1 RNAi